Gmo Emerging Financials
| GMEMX Fund | USD 23.98 0.03 0.13% |
Gmo |
Please note that past performance is not an indicator of the future performance of Gmo Emerging, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future. Therefore, you must use caution to infer that these results indicate any fund, manager, or strategy's future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Gmo Emerging Fund Summary
Gmo Emerging competes with Vanguard Emerging, Vanguard Emerging, American Funds, American Funds, and New World. Under normal circumstances, the fund invests at least 80 percent of the funds net assets directly and indirectly in companies tied economically to markets that are not treated as developed markets in the MSCI World Index . It may invest in securities of companies of any market capitalization.Specialization | Diversified Emerging Mkts, Large Value |
| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| ISIN | US3620075024 |
| Business Address | GMO Trust |
| Mutual Fund Family | GMO |
| Mutual Fund Category | Diversified Emerging Mkts |
| Benchmark | NYSE Composite |
| Phone | 617 346 7646 |
| Currency | USD - US Dollar |
You should never invest in Gmo Emerging Markets without having analyzed available financial metrics that contribute to the net asset value (NAV) of the fund. Do not rely on someone else's analysis or guesses about the future performance of Gmo Mutual Fund, because this is throwing your money away. Analyzing the key information contained in Gmo Emerging's prospectus and an annual reports, can give you an edge over other investors and help to ensure that your investments perform well for you.
Gmo Emerging Key Financial Ratios
Generally speaking, Gmo Emerging's financial ratios allow both analysts and investors to convert raw data from Gmo Emerging's financial statements into concise, actionable information that can be used to evaluate the performance of Gmo Emerging over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Gmo Emerging Markets reports annually and quarterly.Gmo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gmo Emerging's current stock value. Our valuation model uses many indicators to compare Gmo Emerging value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gmo Emerging competition to find correlations between indicators driving Gmo Emerging's intrinsic value. More Info.Gmo Emerging Markets is rated # 4 fund in price to earning among similar funds. It is rated below average in price to book among similar funds fabricating about 0.12 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Gmo Emerging Markets is roughly 8.12 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Gmo Emerging by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Gmo Emerging's Mutual Fund. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Emerging's earnings, one of the primary drivers of an investment's value.Gmo Emerging Markets Systematic Risk
Gmo Emerging's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gmo Emerging volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Gmo Emerging Markets correlated with the market. If Beta is less than 0 Gmo Emerging generally moves in the opposite direction as compared to the market. If Gmo Emerging Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gmo Emerging Markets is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gmo Emerging is generally in the same direction as the market. If Beta > 1 Gmo Emerging moves generally in the same direction as, but more than the movement of the benchmark.
Gmo Emerging April 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Gmo Emerging help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gmo Emerging Markets. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gmo Emerging Markets based on widely used predictive technical indicators. In general, we focus on analyzing Gmo Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gmo Emerging's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.6767 | |||
| Information Ratio | 0.0034 | |||
| Maximum Drawdown | 3.66 | |||
| Value At Risk | (1.08) | |||
| Potential Upside | 1.22 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gmo Emerging Markets. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.